CA2978594C - Agents therapeutiques de type anticorps se liant a cd47 - Google Patents

Agents therapeutiques de type anticorps se liant a cd47

Info

Publication number
CA2978594C
CA2978594C CA2978594A CA2978594A CA2978594C CA 2978594 C CA2978594 C CA 2978594C CA 2978594 A CA2978594 A CA 2978594A CA 2978594 A CA2978594 A CA 2978594A CA 2978594 C CA2978594 C CA 2978594C
Authority
CA
Canada
Prior art keywords
seq
antibody
chain variable
variable domain
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2978594A
Other languages
English (en)
Other versions
CA2978594A1 (fr
Inventor
Barbara A. Swanson
John Dixon Gray
Heyue Zhou
Original Assignee
Yuhan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corp filed Critical Yuhan Corp
Priority claimed from PCT/US2016/020980 external-priority patent/WO2016141328A2/fr
Publication of CA2978594A1 publication Critical patent/CA2978594A1/fr
Application granted granted Critical
Publication of CA2978594C publication Critical patent/CA2978594C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne des compositions et des méthodes associées à des anticorps anti-CD47 ou dérivées de ceux-ci. Plus particulièrement, l'invention concerne des anticorps entièrement humains qui se lient à CD47, des fragments se liant à l'anticorps CD47 et des dérivés desdits anticorps, et des polypeptides se liant à CD47 contenant lesdits fragments. L'invention concerne également des acides nucléiques codant pour lesdits anticorps, fragments et dérivés d'anticorps et polypeptides, des cellules contenant lesdits polynucléotides, des méthodes de production desdits anticorps, fragments et dérivés d'anticorps et polypeptides, et des méthodes utiliser ceux-ci, notamment des méthodes pour traiter une maladie.
CA2978594A 2015-03-04 2016-03-04 Agents therapeutiques de type anticorps se liant a cd47 Active CA2978594C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562128462P 2015-03-04 2015-03-04
US62/128,462 2015-03-04
PCT/US2016/020980 WO2016141328A2 (fr) 2015-03-04 2016-03-04 Agents thérapeutiques de type anticorps se liant à cd47

Publications (2)

Publication Number Publication Date
CA2978594A1 CA2978594A1 (fr) 2016-09-09
CA2978594C true CA2978594C (fr) 2025-09-09

Family

ID=

Similar Documents

Publication Publication Date Title
AU2020294159B2 (en) Antibody therapeutics that bind CD47
US11999792B2 (en) Antibody therapeutics that bind CD38
US10927171B2 (en) Antibody therapeutics that bind TIM3
US11746156B2 (en) Antibody therapeutics that bind CD123
US9969807B2 (en) Antibody therapeutics that bind CD123
CA2978594C (fr) Agents therapeutiques de type anticorps se liant a cd47